Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
June 19, 2020, Evoke Pharma announced the FDA approval of Gimoti (metoclopramide), for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
